Through staff collaboration and the creation of patient narratives in electronic medical records (EMRs), spiritual care plans encourage caregivers to remember the human spirit of their patients with cancer, according [ Read More ]
December 2016 VOL 7, NO 11
Reﬂecting on the Year Past – Looking Forward to the Year Ahead
Lillie D. Shockney, RN, BS, MAS, ONN-CG
As we close out another year, I would like to thank you, our Journal of Oncology Navigation & Survivorship (JONS) reading community, for your support, encouragement, and loyalty. Together we have brought evidence-based navigation research to the forefront of patient care and established it as an indispensable service to ensure best practices and outcomes for our patients. The navigation successes we report in these pages have positively affected the culture of nursing at every phase of care from prevention through survivorship. As the momentum of the navigation movement mounts, we will continue to offer the following in 2017:
- Impact of Navigation Programs
JONS offers original, evidence-based research from navigators demonstrating the positive impact of navigation programs in areas such as patient education, psychosocial support, and improved patient outcomes.
- Live Meetings
To foster professional growth, we encourage all nurse and patient navigators to attend our Academy of Oncology Nurse & Patient Navigators (AONN+) regional and annual meetings.
- Research Opportunities
Interested in conducting research? We provide a venue to submit an abstract of your navigation research at the annual meeting. See our website for details: www.AONNonline.org.
- Interview with the Innovators
JONS conducts interviews with leaders in all sectors of oncology and brings you their game-changing strategies, missions, and impact on patient care.
2016 has been a great year for us, and I look forward to continuing our mission in 2017. I encourage your continued contributions to JONS and AONN+ because our navigation community thrives when we share our successes stories and research with each other. And when we thrive, we are ultimately better able to serve our patients.
It is my pleasure to serve you as Editor-in-Chief of JONS. My very best to you this holiday season and in the New Year.
Lillie D. Shockney, RN, BS, MAS
University Distinguished Service Professor of Breast Cancer, Depts of Surgery and Oncology; Administrative Director, The Johns Hopkins Breast Center; Director, Cancer Survivorship Programs at the Sidney Kimmel Cancer Center at Johns Hopkins; Associate Professor, JHU School of Medicine, Depts of Surgery, Oncology & Gynecology and Obstetrics;
Associate Professor, JHU School of Nursing, Baltimore, MD
The addition of the selective CDK4/6 inhibitor ribociclib to letrozole significantly improved progression-free survival (PFS) in hormone receptor–positive (HR+) advanced breast cancer. Compared with letrozole alone, the combination of ribociclib/letrozole [ Read More ]